Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

BACKGROUND: Recurrent respiratory papillomatosis (RRP) is a human papillomavirus (HPV) driven neoplastic disorder of the upper aerodigestive tract that causes significant morbidity and can lead to fatal airway obstruction. Prior clinical study demonstrated clinical benefit with the programmed death-...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbins, Yvette, Friedman, Jay, Clavijo, Paul E, Sievers, Cem, Bai, Ke, Donahue, Renee N, Schlom, Jeffrey, Sinkoe, Andrew, Abdul Sater, Houssein, Gulley, James L, Norberg, Scott, Hinrichs, Christian S, Allen, Clint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407210/
https://www.ncbi.nlm.nih.gov/pubmed/34462327
http://dx.doi.org/10.1136/jitc-2021-003113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407210/
https://www.ncbi.nlm.nih.gov/pubmed/34462327
http://dx.doi.org/10.1136/jitc-2021-003113

Ejemplares similares